Summary
Thermo Fisher Scientific Inc. (TMO) has filed an 8-K report detailing amendments to its By-Laws, effective February 23, 2021. The most significant change for investors is the introduction of a provision allowing stockholders who collectively own at least 25% of the outstanding common stock to call a special meeting. This grants a greater degree of shareholder influence over corporate governance, potentially enabling more proactive engagement on significant issues. Additionally, the By-Laws have been updated to clarify document delivery procedures and establish special meeting requirements for the Board of Directors during emergencies. These updates also include conforming the By-Laws to current Delaware General Corporation Law and removing obsolete provisions, reflecting a commitment to maintaining current and compliant corporate governance practices.
Key Highlights
- 1Stockholders holding at least 25% of common stock can now call a special meeting.
- 2Amendments to By-Laws are effective as of February 23, 2021.
- 3Clarified procedures for delivering documents to the Company.
- 4Established special procedural requirements for Board meetings during emergencies.
- 5By-Laws updated to conform with Delaware General Corporation Law.
- 6Obsolete provisions within the By-Laws have been eliminated.
- 7The filing includes the Amended and Restated By-Laws as an exhibit.